These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 9426709

  • 21. Prostate cancer: non-metastatic.
    Wilt T.
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract] [Full Text] [Related]

  • 22. What is the best postoperative treatment for patients with pT3bN0M0 adenocarcinoma of the prostate?
    Kasibhatla M, Peterson B, Anscher MS.
    Prostate Cancer Prostatic Dis; 2005 Jun; 8(2):167-73. PubMed ID: 15711603
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M, Hirano D, Takimoto Y, Kamoto T, Ogawa O, Sumiyoshi Y, Shimazaki J, Kakizoe T, Japanese Study Group for Locally Advanced Prostate Cancer.
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [Abstract] [Full Text] [Related]

  • 26. Management of stage pTxN+ adenocarcinoma of the prostate: influence of radical prostatectomy on progression-free interval.
    Wu TT, Lu CM, Lee YH, Hwang JK.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):514-20. PubMed ID: 10462828
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Controversies in the treatment of prostate cancer with maximal androgen deprivation.
    McLeod DG, Moul JW.
    Surg Oncol Clin N Am; 1995 Apr; 4(2):345-59. PubMed ID: 7796290
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A.
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract] [Full Text] [Related]

  • 31. [Treatment of clinically localized prostatic cancer--endocrine therapy].
    Hirano A.
    Hinyokika Kiyo; 1996 Oct; 42(10):829-32. PubMed ID: 8951483
    [Abstract] [Full Text] [Related]

  • 32. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
    Bastide C, Kuefer R, Loeffler M, de Petriconi R, Gschwend J, Hautmann R.
    Prostate Cancer Prostatic Dis; 2006 Oct; 9(3):239-44. PubMed ID: 16832384
    [Abstract] [Full Text] [Related]

  • 33. Total androgenic blockade: a review.
    Bianchi G, Beltrami P, Motta L, Mobilio G.
    Acta Urol Belg; 1995 Sep; 63(3):11-9. PubMed ID: 7484517
    [No Abstract] [Full Text] [Related]

  • 34. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
    Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H.
    J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
    [Abstract] [Full Text] [Related]

  • 35. Intermittent complete androgen blockade in PSA relapse after radical prostatectomy and incidental prostate cancer.
    Kurek R, Renneberg H, Lübben G, Kienle E, Tunn UW.
    Eur Urol; 1999 Jan; 35 Suppl 1():27-31. PubMed ID: 10081700
    [Abstract] [Full Text] [Related]

  • 36. [Loss of differentiation of a prostate adenocarcinoma after hormone therapy: the example of a metastasis in the spongy body of the penis].
    Uphoff J, Woziwodzki J, Schattka SO, Kollias A.
    Aktuelle Urol; 2008 Sep; 39(5):373-7. PubMed ID: 18798127
    [Abstract] [Full Text] [Related]

  • 37. [LHRH analogues for the treatment of prostate cancer: an evidence level-based analysis].
    Pfitzenmaier J, Altwein JE.
    Aktuelle Urol; 2009 Mar; 40(2):100-8. PubMed ID: 19253209
    [Abstract] [Full Text] [Related]

  • 38. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
    Wieder JA, Soloway MS.
    J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867
    [Abstract] [Full Text] [Related]

  • 39. [The hormonal and chemotherapy of prostatic cancer].
    Miron L.
    Rev Med Chir Soc Med Nat Iasi; 1996 Aug; 100(3-4):37-43. PubMed ID: 9455433
    [Abstract] [Full Text] [Related]

  • 40. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection.
    Epstein JI.
    Semin Oncol; 1994 Oct; 21(5):527-41. PubMed ID: 7939746
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.